Approximately one in nine newborns with Down syndrome failed a routine car seat tolerance screening before hospital discharge in a first-of-its-kind study at the University of Maryland Golisano Children’s Hospital (UMGCH).
University of Maryland School of Medicine (UMSOM) researchers have identified a target that may improve the response of CAR T-cell therapy, a treatment for patients with recurrent or difficult-to-treat blood cancers.
The University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) is the first in the Maryland, Delaware, Virginia and Washington D.C. region to offer an innovative cell therapy treatment for patients with an advanced type of soft tissue cancer known as synovial sarcoma. This single-infusion T-cell therapy, called TCR-T therapy, involves engineering a patient’s own white blood cells to re
A 41-year-old Silver Spring woman who has endured debilitating pain crises and frequent hospitalizations throughout much of her life as the result of sickle cell disease has been treated at the University of Maryland Medical Center (UMMC) with her own genetically engineered stem cells in an effort to prevent life-threatening complications and achieve a long-term cure.
A large multicenter clinical trial found no benefit to using two antibiotic powders — vancomycin, which targets gram-positive bacteria seen commonly in surgical infections, and tobramycin, which targets gram-negative bacteria that can also cause infection after fracture — during surgery for high-risk leg fractures involving the shin bone.
